Exhale

The official blog of the Lung Institute.

The Lung Institute earns The Joint Commission’s Gold Seal of Approval

30 Jan 2018
| Under Featured | Posted by
| 8 Comments
The Lung Institute earns The Joint Commission's Gold Seal of Approval

We, at the Lung Institute, are proud to announce we have earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation. This prestigious accreditation is given to organizations that demonstrate continuous compliance with The Joint Commission’s nationally recognized standards.

The Gold Seal of Approval® is a symbol of high quality that reflects our commitment to providing safe and effective patient care.

Unannounced December Review

The accreditation review process began with a rigorous, unannounced onsite survey from Dec. 4-6, 2017. During the review, a Joint Commission surveyor experienced in ambulatory health care, evaluated compliance with ambulatory care standards, including coordination of care, monitoring for procedures that involve use of sedation or anesthesia, infection prevention and control, management of medications, and patient education and training.

“The Lung Institute is pleased to receive accreditation from The Joint Commission, the premier health care quality improvement and accrediting body in the nation,” said Jimmy St. Louis, founder and CEO of Regenerative Medicine Solutions. “Our team is passionate and committed to a patient-first approach and bringing together leaders in the regenerative medicine and wellness communities that improve the lives of those suffering from chronic lung disorders.”

Lung Institute in Select Company

Today, The Joint Commission’s Ambulatory Health Care Accreditation Program serves 2,100 ambulatory care providers with more than 8,500 sites of care which, in turn, serve more than 83 million patient visits annually.

The Joint Commission’s ambulatory health care standards are developed in consultation with health care experts and providers, measurement experts, and patients. The standards are informed by scientific literature and expert consensus to help organizations measure, assess and improve performance.

To read the complete press release, click here.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.